Insider Selling: Axon Enterprise, Inc (NASDAQ:AXON) President Sells 905 Shares of Stock

Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report) President Joshua Isner sold 905 shares of the stock in a transaction on Tuesday, June 17th. The stock was sold at an average price of $776.39, for a total value of $702,632.95. Following the completion of the transaction, the president now owns 268,735 shares in the company, valued at approximately $208,643,166.65. This represents a 0.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Joshua Isner also recently made the following trade(s):

• On Wednesday, May 21st, Joshua Isner sold 9,905 shares of Axon Enterprise stock. The shares were sold at an average price of $738.03, for a total transaction of $7,310,187.15.
• On Monday, May 12th, Joshua Isner sold 9,000 shares of Axon Enterprise stock. The shares were sold at an average price of $683.31, for a total transaction of $6,149,790.00.

Axon Enterprise Stock Performance

NASDAQ:AXON traded down $6.75 during trading on Wednesday, reaching $770.79. The company's stock had a trading volume of 482,785 shares, compared to its average volume of 713,156. Axon Enterprise, Inc has a 12 month low of $279.02 and a 12 month high of $806.64. The firm has a market cap of $60.01 billion, a price-to-earnings ratio of 186.18, a price-to-earnings-growth ratio of 89.86 and a beta of 1.29. The firm has a 50 day moving average of $679.36 and a 200-day moving average of $623.45. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.62 and a current ratio of 2.83.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. The business had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The firm's quarterly revenue was up 31.3% compared to the same quarter last year. During the same quarter last year, the company posted $1.15 earnings per share. Research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Institutional Investors Weigh In On Axon Enterprise

Several large investors have recently modified their holdings of AXON. TCTC Holdings LLC lifted its stake in Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock valued at $29,000 after purchasing an additional 24 shares during the last quarter. Fourth Dimension Wealth LLC purchased a new position in shares of Axon Enterprise during the 4th quarter valued at $30,000. Bartlett & CO. Wealth Management LLC grew its stake in shares of Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after acquiring an additional 33 shares during the period. Banque Transatlantique SA purchased a new stake in Axon Enterprise in the 1st quarter worth about $31,000. Finally, Catalyst Capital Advisors LLC purchased a new stake in Axon Enterprise in the 1st quarter worth about $32,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Analyst Ratings Changes

Several research firms have recently commented on AXON. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Needham & Company LLC raised their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. Barclays upped their price target on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Finally, Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $699.55.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.